Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Mallinckrodt Pays $117M for This Bay Area Biotech and Its Failed Liver Drug November 1, 2017 Novartis Buys Rare Drug Voucher for $130M From Ultragenyx December 17, 2017 PRA Health Sciences Announces The Center For Pediatric Clinical Development May 3, 2017